Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Addiction Science & Clinical Practice|June 10, 2025
The peers expanding engagement in stimulant harm reduction with contingency management study: a protocol paperAlexis Cooke, Erin Stack, Linda Peng, et al.
BMC Public Health|September 22, 2021
Use of methamphetamine and alcohol among people with opioid use disorder and HIV in Vietnam: a qualitative studyAndrew Edsall, Kim A Hoffman, Dinh Thanh Thuy, et al.
Addiction (Abingdon, England)|January 7, 2017
Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trialPhilip T Korthuis, Paula J Lum, Pamela Vergara-Rodriguez, et al.
The Lancet. HIV|February 4, 2021
HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trialP Todd Korthuis, Caroline King, Ryan R Cook, et al.
Drug and Alcohol Dependence|September 20, 2005
Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness studyKathleen M Carroll, Samuel A Ball, Charla Nich, et al.
Health & Justice|December 18, 2022
The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional studyElizabeth C Saunders, Milan F Satcher, Laura B Monico, et al.
Journal of the American Chemical Society|April 24, 2024
Ultrafast Au(III)-Mediated Arylation of CysteineEvan A Doud, James A R Tilden, Joseph W Treacy, et al.
Substance Abuse|February 12, 2015
The Use of Technology in Participant Tracking and Study Retention: Lessons Learned From a Clinical Trials Network StudyShannon Gwin Mitchell, Robert P Schwartz, Anika A H Alvanzo, et al.
Addiction (Abingdon, England)|February 7, 2022
HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trialP Todd Korthuis, Ryan R Cook, Paula J Lum, et al.
Pageof 7